Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Training Set for the Homologous Recombination Deficiency Scoring Model With Loss of Heterozygosity Status in Epithelial Ovarian Cancer

NCT04651933 is registered in ClinicalTrials.gov with Lei Li as lead sponsor.

NCT NCT04651933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04651933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Training Set for the Homologous Recombination Deficiency Scoring Model With Loss of Heterozygosity Status in Epithelial Ovarian Cancer
Lead sponsor
Lei Li
Phase
Observational
Overall status
Unknown status
Start date
November 26, 2020
Completion date
November 26, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca mutation, epithelial ovarian cancer, homologous recombination deficiency, loss of heterozygosity, platinum resistance, prognosis